Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid.
Oral administration of 13-cis-retinoic acid (40 or 160 milligrams per kilogram of body weight daily) significantly reduced the inflammation associated with developing and established adjuvant arthritis, an experimentally induced arthritis in rats that resembles human rheumatoid arthritis. The amount of collagenase secreted in tissue culture by adherent cells isolated from the inflamed joints of adjuvant rats treated with 13-cis-retinoic acid also decreased as compared to the amount secreted by cells from vehicle-treated adjuvant rats. Collagenase is important in the joint destruction accompanying rheumatoid arthritis. The successful use of retinoids in the treatment of this proliferative but nonmalignant disorder demonstrates a new application of these compounds.
D000818:Animals; D001168:Arthritis / Q000188:drug therapy*; D001169:Arthritis, Experimental / Q000188:drug therapy*; D005260:Female; D005340:Fibrinogen / Q000097:blood; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D003012:Microbial Collagenase / Q000096:biosynthesis; D011458:Prostaglandins E / Q000096:biosynthesis; D051381:Rats; D012737:Sex Factors; D014212:Tretinoin / Q000627:therapeutic use*
D011458:Prostaglandins E; D014212:Tretinoin; D005340:Fibrinogen; D003012:Microbial Collagenase